MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure
暂无分享，去创建一个
P. Erben | R. Hehlmann | A. Fabarius | A. Hochhaus | D. Wolf | T. Ernst | B. Hanfstein | MC Müller | R. Woodman | D. Purkayastha | R. Woodman | S. Saussele | M. Agrawal | W. Hofmann | M. Müller | A. Hochhaus | Susanne Saussele | Ruediger Hehlmann | Benjamin Hanfstein | Susanne Saußele | Philipp Erben | Dominik Wolf | Richard C. Woodman | W. Hofmann